Anandamide-induced depressor effect in spontaneously hypertensive rats: role of the vanilloid receptor
- PMID: 12623992
- DOI: 10.1161/01.HYP.0000051641.58674.F7
Anandamide-induced depressor effect in spontaneously hypertensive rats: role of the vanilloid receptor
Abstract
To test the hypothesis that activation of the vanilloid receptor (VR1) contributes to the anandamide-induced depressor effect in spontaneously hypertensive rats (SHR), we used a selective VR1 antagonist capsazepine (CAPZ) and a selective cannabinoid type 1 receptor antagonist SR141716A in conjunction with a VR1 agonist capsaicin in both SHR and Wistar-Kyoto rats (WKY). Mean arterial pressure was increased in SHR compared with WKY (P<0.05). Intravenous administration of capsaicin caused a greater depressor response in SHR compared with WKY (P<0.05), which was blocked by approximately 60% by CAPZ (P<0.05) in SHR only. Methanandamide caused a similar greater depressor response (P<0.05), which was blocked by approximately 50% and 60% by CAPZ and SR141716A, respectively, in SHR (P<0.05) but not in WKY. Radioimmunoassay showed that methanandamide increased plasma calcitonin gene-related peptide (CGRP) levels from baseline in both SHR and WKY (P<0.05), with no difference between 2 strains. Western blot showed that protein expression for the calcitonin receptor-like receptor-but not receptor activity modifying protein 1, VR1, and cannabinoid type 1 receptors-was increased in mesenteric resistance arteries in SHR compared with WKY (P<0.05). These data indicate that in addition to activation of cannabinoid type 1, anandamide may serve as an endogenous compound to stimulate VR1, leading to a decrease in blood pressure via CGRP release from sensory nerve terminals. Increased mesenteric CGRP receptor expression in SHR may account for increased sensitivity of blood pressure to anandamide and may serve as a compensatory response to buffer the increase in blood pressure in SHR.
Similar articles
-
VR1-mediated depressor effects during high-salt intake: role of anandamide.Hypertension. 2005 Oct;46(4):986-91. doi: 10.1161/01.HYP.0000174596.95607.fd. Epub 2005 Sep 6. Hypertension. 2005. PMID: 16144988
-
Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anaesthetized rats.Naunyn Schmiedebergs Arch Pharmacol. 2001 Dec;364(6):562-9. doi: 10.1007/s00210-001-0498-6. Naunyn Schmiedebergs Arch Pharmacol. 2001. PMID: 11770012
-
Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro.Eur J Neurosci. 2003 Jun;17(12):2611-8. doi: 10.1046/j.1460-9568.2003.02703.x. Eur J Neurosci. 2003. PMID: 12823468
-
New perspectives on enigmatic vanilloid receptors.Trends Neurosci. 2000 Oct;23(10):491-7. doi: 10.1016/s0166-2236(00)01630-1. Trends Neurosci. 2000. PMID: 11006466 Review.
-
Cardiovascular pharmacology of anandamide.Prostaglandins Leukot Essent Fatty Acids. 2002 Feb-Mar;66(2-3):343-51. doi: 10.1054/plef.2001.0346. Prostaglandins Leukot Essent Fatty Acids. 2002. PMID: 12052048 Review.
Cited by
-
Vascular effects of anandamide and N-acylvanillylamines in the human forearm and skin microcirculation.Br J Pharmacol. 2005 Sep;146(2):171-9. doi: 10.1038/sj.bjp.0706313. Br J Pharmacol. 2005. PMID: 15997233 Free PMC article.
-
Modulation of the endocannabinoid system in cardiovascular disease: therapeutic potential and limitations.Hypertension. 2008 Oct;52(4):601-7. doi: 10.1161/HYPERTENSIONAHA.105.063651. Epub 2008 Sep 8. Hypertension. 2008. PMID: 18779440 Free PMC article. Review. No abstract available.
-
The Association Between Blood Pressure and Headache in Postmenopausal Women: A Prospective Hospital-Based Study.Int J Gen Med. 2021 Jun 16;14:2563-2568. doi: 10.2147/IJGM.S317780. eCollection 2021. Int J Gen Med. 2021. PMID: 34163225 Free PMC article.
-
Search for an endogenous cannabinoid-mediated effect in the sympathetic nervous system.Naunyn Schmiedebergs Arch Pharmacol. 2005 Jan;371(1):9-17. doi: 10.1007/s00210-004-1003-9. Epub 2005 Jan 20. Naunyn Schmiedebergs Arch Pharmacol. 2005. PMID: 15660243
-
Cannabinoids, endocannabinoids, and related analogs in inflammation.AAPS J. 2009 Mar;11(1):109-19. doi: 10.1208/s12248-009-9084-5. Epub 2009 Feb 6. AAPS J. 2009. PMID: 19199042 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials